Clinical Trial Update: Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating mepolizumab for rhinovirus-induced asthma exacerbations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Asthma, Viral Infection | Phase 3 | Status: UNKNOWN